Oncology & Cancer
Antibody-guided drug works against acute lymphoblastic leukemia
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be ...
May 23, 2011
0
0
